Alnylam Pharmaceuticals, Inc. (ALNY)

310.89 +2.46 (+0.80%) USD  |  NASDAQ  |  Apr 22, 15:08
More

Alnylam Pharmaceuticals Buy Recommendations

Buy Recommendations Chart

View Buy Recommendations for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Buy Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Buy Recommendations Range, Past 5 Years

View Buy Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Buy Recommendations Benchmarks

View Buy Recommendations Benchmarks
Start Trial
Pfizer Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Eli Lilly & Co. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade